scorecardresearchAfter a 20% fall in 2022, Elara Capital sees a 40% upside in this stock

After a 20% fall in 2022, Elara Capital sees a 40% upside in this stock

Updated: 31 May 2022, 04:06 PM IST
TL;DR.
Higher occupancy and specialized surgeries at mature and new facilities and the addition of new pharmacy stores are expected to boost growth, noted the brokerage.
Higher occupancy and specialized surgeries at mature and new facilities and the addition of new pharmacy stores are expected to boost growth, noted the brokerage.

Higher occupancy and specialized surgeries at mature and new facilities and the addition of new pharmacy stores are expected to boost growth, noted the brokerage.